HLF
Herbalife Ltd.
NYSEUSDEQUITY
DELAYED
Last price
12.40
▲ 0.25 (2.06%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
12.05
Prev close
12.15
Day high
12.74
Day low
12.09
Volume
1.09M
Market cap
—
P/E (TTM)
—
52W range
7.56 – 20.40
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
+2.60%
+4.0%
1M
+7.20%
+3.5%
3M
-0.32%
-3.4%
6M
-36.62%
-47.7%
YTD
-1.86%
-14.2%
1Y
+34.43%
+14.4%
3Y
-19.58%
-93.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $5.04B | $4.99B | $5.06B | $5.20B | +0.9% |
| Operating revenue | $5.04B | $4.99B | $5.06B | $5.20B | +0.9% |
| Cost of revenue | $1.11B | $1.10B | $1.19B | $1.17B | +0.9% |
| Gross profit | $3.92B | $3.89B | $3.87B | $4.03B | +0.9% |
| Selling, general & admin | $3.45B | $3.51B | $3.53B | $1.81B | -1.8% |
| Total operating expense | $3.44B | $3.50B | $3.52B | $3.49B | -1.7% |
| Operating income | $481.00M | $385.90M | $356.40M | $545.20M | +24.6% |
| Net interest income | -$205.90M | -$206.00M | -$154.40M | -$133.20M | +0.0% |
| Pre-tax income | $275.10M | $169.40M | $203.00M | $424.80M | +62.4% |
| Tax provision | $47.30M | -$84.90M | $60.80M | $103.50M | +155.7% |
| Net income | $228.30M | $254.30M | $142.20M | $321.30M | -10.2% |
| Net income to common | $228.30M | $254.30M | $142.20M | $321.30M | -10.2% |
| Basic EPS | 2.22 | 2.53 | 1.44 | 3.26 | -12.3% |
| Diluted EPS | 2.20 | 2.50 | 1.42 | 3.23 | -12.0% |
| EBIT | $489.50M | $387.70M | $368.90M | $564.10M | +26.3% |
| EBITDA | $610.70M | $509.10M | $482.20M | $679.50M | +20.0% |
| Basic shares | 102.80M | 100.60M | 99.00M | 98.50M | +2.2% |
| Diluted shares | 103.60M | 101.60M | 100.20M | 99.50M | +2.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $353.10M | $415.30M | $575.20M | $508.00M | -15.0% |
| Cash & short-term investments | $353.10M | $415.30M | $575.20M | $508.00M | -15.0% |
| Accounts receivable | $91.90M | $68.90M | $81.20M | $70.60M | +33.4% |
| Inventory | $511.70M | $475.40M | $505.20M | $580.70M | +7.6% |
| Total current assets | $1.14B | $1.14B | $1.40B | $1.36B | +0.1% |
| Property, plant & equipment | $616.00M | $645.90M | $692.30M | $693.40M | -4.6% |
| Goodwill & intangibles | $415.60M | $400.00M | $409.40M | $408.90M | +3.9% |
| Total assets | $2.79B | $2.73B | $2.81B | $2.73B | +2.1% |
| Total current liabilities | $1.01B | $1.23B | $1.28B | $976.60M | -17.7% |
| Current debt | $20.90M | $283.50M | $309.50M | $29.50M | -92.6% |
| Long-term debt | $1.97B | $1.98B | $2.25B | $2.66B | -0.2% |
| Total debt | $2.18B | $2.47B | $2.77B | $2.92B | -11.6% |
| Total liabilities | $3.30B | $3.53B | $3.87B | $4.00B | -6.6% |
| Retained earnings | -$579.70M | -$808.00M | -$1.06B | -$1.20B | +28.3% |
| Shareholder equity | -$515.10M | -$801.10M | -$1.06B | -$1.27B | +35.7% |
| Working capital | $131.80M | -$86.70M | $121.70M | $379.50M | +252.0% |
| Net tangible assets | -$930.70M | -$1.20B | -$1.47B | -$1.67B | +22.5% |
| Shares issued | 103.31M | 101.20M | 99.20M | 97.90M | +2.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $227.80M | $254.30M | $142.20M | $321.30M | -10.4% |
| Depreciation & amortisation | $121.20M | $121.40M | $113.30M | $115.40M | -0.2% |
| Stock-based compensation | $44.10M | $50.00M | $48.00M | $44.40M | -11.8% |
| Change in working capital | -$35.50M | $32.50M | $47.70M | -$123.10M | -209.2% |
| Operating cash flow | $333.30M | $285.40M | $357.50M | $352.50M | +16.8% |
| Capital expenditure | -$80.40M | -$122.00M | -$135.00M | -$156.40M | +34.1% |
| Investing cash flow | -$108.70M | -$84.60M | -$134.80M | -$156.20M | -28.5% |
| Financing cash flow | -$295.50M | -$335.30M | -$148.30M | -$264.70M | +11.9% |
| Free cash flow | $252.90M | $163.40M | $222.50M | $196.10M | +54.8% |
| End cash position | $375.30M | $438.10M | $595.50M | $516.30M | -14.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $1.33B | $1.32B | $1.28B | $1.27B | $1.26B | +0.7% |
| Operating revenue | $1.33B | $1.32B | $1.28B | $1.27B | $1.26B | +0.7% |
| Cost of revenue | $296.30M | $291.10M | $288.30M | $284.20M | $276.90M | +1.8% |
| Gross profit | $1.03B | $1.03B | $994.70M | $989.50M | $982.20M | +0.4% |
| Selling, general & admin | $902.20M | $893.20M | $2.12B | $447.60M | $854.40M | +1.0% |
| Total operating expense | $902.20M | $887.70M | $894.90M | $863.70M | $849.60M | +1.6% |
| Operating income | $128.30M | $138.40M | $99.80M | $125.80M | $132.60M | -7.3% |
| Net interest income | -$37.40M | -$46.80M | -$49.30M | -$51.00M | -$53.60M | +20.1% |
| Pre-tax income | -$3.70M | $91.60M | $50.50M | $74.80M | $79.00M | -104.0% |
| Tax provision | $22.80M | $30.40M | -$34.60M | $31.70M | $29.80M | -25.0% |
| Net income | -$26.30M | $61.20M | $85.60M | $43.20M | $49.30M | -143.0% |
| Net income to common | -$26.30M | $61.20M | $85.60M | $43.20M | $49.30M | -143.0% |
| Basic EPS | -0.25 | 0.60 | 0.83 | 0.42 | 0.48 | -141.7% |
| Diluted EPS | -0.25 | 0.57 | 0.81 | 0.42 | 0.48 | -143.9% |
| EBIT | $36.30M | $141.10M | $101.90M | $127.80M | $134.40M | -74.3% |
| EBITDA | $67.70M | $170.50M | $131.20M | $158.50M | $164.90M | -60.3% |
| Basic shares | 104.50M | 103.80M | 103.50M | 103.30M | 102.70M | +0.7% |
| Diluted shares | 104.50M | 108.40M | 105.00M | 104.00M | 103.30M | -3.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $370.50M | $451.20M | $353.10M | $305.50M | $320.90M | -17.9% |
| Cash & short-term investments | $370.50M | $451.20M | $353.10M | $305.50M | $320.90M | -17.9% |
| Accounts receivable | $115.90M | $106.00M | $91.90M | $97.80M | $96.20M | +9.3% |
| Inventory | $507.70M | $494.60M | $511.70M | $512.50M | $513.10M | +2.6% |
| Total current assets | $1.17B | $1.25B | $1.14B | $1.11B | $1.10B | -6.7% |
| Property, plant & equipment | $579.20M | $598.30M | $616.00M | $628.40M | $647.60M | -3.2% |
| Goodwill & intangibles | $459.10M | $413.70M | $415.60M | $416.70M | $417.50M | +11.0% |
| Total assets | $2.86B | $2.88B | $2.79B | $2.70B | $2.74B | -0.6% |
| Total current liabilities | $973.50M | $1.02B | $1.01B | $999.90M | $1.09B | -4.8% |
| Current debt | $12.00M | $9.20M | $20.90M | $20.70M | $168.00M | +30.4% |
| Long-term debt | $2.00B | $1.98B | $1.97B | $2.00B | $1.97B | +1.1% |
| Total debt | $2.20B | $2.18B | $2.18B | $2.21B | $2.35B | +1.0% |
| Total liabilities | $3.32B | $3.31B | $3.30B | $3.30B | $3.39B | +0.5% |
| Retained earnings | -$544.10M | -$517.80M | -$579.70M | -$665.10M | -$708.30M | -5.1% |
| Shareholder equity | -$474.50M | -$441.50M | -$515.10M | -$612.00M | -$660.50M | -7.5% |
| Working capital | $195.30M | $230.00M | $131.80M | $106.30M | $8.60M | -15.1% |
| Net tangible assets | -$933.60M | -$855.20M | -$930.70M | -$1.03B | -$1.08B | -9.2% |
| Shares issued | 104.80M | 103.41M | 103.31M | 103.20M | 103.10M | +1.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$26.50M | $61.20M | $85.10M | $43.10M | $49.20M | -143.3% |
| Depreciation & amortisation | $31.40M | $29.40M | $29.30M | $30.70M | $30.50M | +6.8% |
| Stock-based compensation | $10.10M | $10.60M | $10.90M | $11.20M | $10.40M | -4.7% |
| Change in working capital | -$77.20M | $4.10M | $36.70M | $15.90M | $6.80M | -1,982.9% |
| Operating cash flow | $32.90M | $113.80M | $98.30M | $138.80M | $96.00M | -71.1% |
| Capital expenditure | -$11.30M | -$10.90M | -$18.50M | -$20.80M | -$22.80M | -3.7% |
| Investing cash flow | -$21.60M | -$11.20M | -$18.70M | -$20.60M | -$50.60M | -92.9% |
| Share buybacks | -$9.30M | -$700.00K | -$100.00K | -$1.30M | -$4.60M | -1,228.6% |
| Financing cash flow | -$82.70M | $2.00M | -$32.70M | -$130.40M | -$60.20M | -4,235.0% |
| Free cash flow | $21.60M | $102.90M | $79.80M | $118.00M | $73.20M | -79.0% |
| End cash position | $393.40M | $473.00M | $375.30M | $328.00M | $343.60M | -16.8% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
12.10
+2.45% from price
SMA 20
12.26
+3.22% from price
SMA 50
12.34
+2.50% from price
SMA 100
13.27
-6.59% from price
SMA 200
13.91
-9.06% from price
EMA 12
12.25
+1.20% from price
EMA 26
12.27
+1.04% from price
EMA 50
12.48
-0.64% from price
RSI (14)
54.4
Neutral
MACD (12,26,9)
-0.02
Hist 0.06
ATR (14)
0.61
4.81% of price
Realised vol 30D
53.8%
Annualised
Bollinger upper
13.01
20, 2σ
Bollinger lower
11.50
20, 2σ
50 / 200 cross
Death
12.34 vs 13.91
Trend bias
Below 200
-9.06%
Risk profile
Beta vs SPY
1.18
More volatile than market
Correlation to SPY
0.26
Largely independent
Realised vol 30D
53.8%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-43.4%
Peak to trough
Max drawdown 5Y
-90.6%
Peak to trough
ATR 14
0.61
4.81% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Q2 Rundown: Herbalife (NYSE:HLF) Vs Other Personal Care Stocks
StockStory · 1d ago
1 Russell 2000 Stock with Competitive Advantages and 2 We Turn Down
StockStory · 2d ago
Is Herbalife Ltd (HLF) Stock Undervalued Right Now?
Zacks · 4d ago
Herbalife Reinforces Commitment to Metabolic Wellness and Healthy Ageing at IISc's RISE for Healthy Ageing Conference 2026
PR Newswire · 6d ago
3 Profitable Stocks with Questionable Fundamentals
StockStory · 6d ago
Herbalife to Present and Host 1x1 Investor Meetings at Midwest IDEAS Investor Conference on August 26
Business Wire · 10d ago
1 Small-Cap Stock Worth Your Attention and 2 We Brush Off
StockStory · 12d ago
Herbalife Q2 Earnings Call Highlights
MarketBeat · 15d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.